Luis Barbeito
| search externally: |
 Springer,
|
Lectures:
keynote
Masitinib for the treatment of amyotrophic lateral sclerosis (ALS): preclinical overview
as author at European Network to Cure ALS (ENCALS), Ljubljana 2017, 38 views |
keynote
Masitinib as an add-on therapy to riluzole is beneficial in the treatment of amyotrophic lateral sclerosis (ALS) with acceptable tolerability: Results from a randomized controlled phase 3 trial
as author at European Network to Cure ALS (ENCALS), Ljubljana 2017, together with: Olivier Hermine, Jesús S. Mora, 158 views |
|||||||
